Statera Biopharma Price History
STABDelisted Stock | USD 0.04 0.0003 0.82% |
If you're considering investing in Statera Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Statera Biopharma stands at 0.04, as last reported on the 15th of December 2024, with the highest price reaching 0.04 and the lowest price hitting 0.04 during the day. We have found twenty-three technical indicators for Statera Biopharma, which you can use to evaluate the volatility of the company. Please validate Statera Biopharma's Variance of 145.01, risk adjusted performance of (0.09), and Coefficient Of Variation of (734.48) to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Statera Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Statera |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
STAB |
Based on monthly moving average Statera Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Statera Biopharma by adding Statera Biopharma to a well-diversified portfolio.
Statera Biopharma Pink Sheet Price History Chart
There are several ways to analyze Statera Stock price data. The simplest method is using a basic Statera candlestick price chart, which shows Statera Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Statera Pink Sheet Price History Data
The price series of Statera Biopharma for the period between Mon, Sep 16, 2024 and Sun, Dec 15, 2024 has a statistical range of 0.11 with a coefficient of variation of 46.58. The price distribution for the period has arithmetic mean of 0.08. The median price for the last 90 days is 0.09. The company completed stock split (1:20) on 28th of January 2015.Open | High | Low | Close | Volume | ||
12/15/2024 | 0.04 | 0.04 | 0.04 | 0.04 | ||
02/07/2023 | 0.04 | 0.04 | 0.04 | 0.04 | 744,886 | |
02/06/2023 | 0.05 | 0.05 | 0.03 | 0.04 | 1,029,015 | |
02/03/2023 | 0.03 | 0.04 | 0.03 | 0.04 | 1,453,492 | |
02/02/2023 | 0.04 | 0.04 | 0.03 | 0.03 | 946,205 | |
02/01/2023 | 0.03 | 0.04 | 0.03 | 0.04 | 886,654 | |
01/31/2023 | 0.03 | 0.03 | 0.03 | 0.03 | 1,048,567 | |
01/30/2023 | 0.03 | 0.03 | 0.03 | 0.03 | 373,719 | |
01/27/2023 | 0.03 | 0.03 | 0.03 | 0.03 | 853,436 | |
01/26/2023 | 0.03 | 0.03 | 0.03 | 0.03 | 577,663 | |
01/25/2023 | 0.03 | 0.04 | 0.03 | 0.03 | 1,335,098 | |
01/24/2023 | 0.03 | 0.04 | 0.03 | 0.03 | 1,946,329 | |
01/23/2023 | 0.03 | 0.04 | 0.03 | 0.03 | 3,860,469 | |
01/20/2023 | 0.04 | 0.04 | 0.03 | 0.03 | 1,815,435 | |
01/19/2023 | 0.04 | 0.04 | 0.03 | 0.03 | 1,208,892 | |
01/18/2023 | 0.04 | 0.04 | 0.04 | 0.04 | 794,847 | |
01/17/2023 | 0.04 | 0.04 | 0.03 | 0.04 | 2,377,000 | |
01/13/2023 | 0.05 | 0.05 | 0.04 | 0.04 | 2,170,400 | |
01/12/2023 | 0.07 | 0.08 | 0.03 | 0.05 | 5,398,300 | |
01/11/2023 | 0.09 | 0.11 | 0.09 | 0.09 | 3,481,200 | |
01/10/2023 | 0.09 | 0.10 | 0.09 | 0.10 | 2,150,800 | |
01/09/2023 | 0.09 | 0.09 | 0.08 | 0.09 | 1,722,200 | |
01/06/2023 | 0.09 | 0.09 | 0.09 | 0.09 | 985,500 | |
01/05/2023 | 0.10 | 0.10 | 0.09 | 0.09 | 2,319,102 | |
01/04/2023 | 0.09 | 0.11 | 0.09 | 0.10 | 3,677,100 | |
01/03/2023 | 0.09 | 0.10 | 0.08 | 0.09 | 1,898,400 | |
12/30/2022 | 0.09 | 0.09 | 0.08 | 0.08 | 1,882,400 | |
12/29/2022 | 0.10 | 0.10 | 0.09 | 0.09 | 1,309,800 | |
12/28/2022 | 0.09 | 0.09 | 0.09 | 0.09 | 1,311,000 | |
12/27/2022 | 0.09 | 0.14 | 0.09 | 0.09 | 9,261,200 | |
12/23/2022 | 0.10 | 0.10 | 0.09 | 0.09 | 644,900 | |
12/22/2022 | 0.10 | 0.10 | 0.10 | 0.10 | 622,900 | |
12/21/2022 | 0.11 | 0.11 | 0.10 | 0.10 | 906,000 | |
12/20/2022 | 0.10 | 0.11 | 0.10 | 0.11 | 934,600 | |
12/19/2022 | 0.11 | 0.11 | 0.10 | 0.11 | 1,231,300 | |
12/16/2022 | 0.10 | 0.12 | 0.10 | 0.11 | 693,200 | |
12/15/2022 | 0.10 | 0.11 | 0.10 | 0.11 | 915,700 | |
12/14/2022 | 0.12 | 0.12 | 0.11 | 0.11 | 1,410,600 | |
12/13/2022 | 0.12 | 0.12 | 0.10 | 0.11 | 1,274,200 | |
12/12/2022 | 0.12 | 0.12 | 0.11 | 0.11 | 1,055,900 | |
12/09/2022 | 0.12 | 0.12 | 0.11 | 0.12 | 639,700 | |
12/08/2022 | 0.12 | 0.13 | 0.11 | 0.12 | 1,070,200 | |
12/07/2022 | 0.11 | 0.14 | 0.11 | 0.12 | 3,656,400 | |
12/06/2022 | 0.11 | 0.13 | 0.11 | 0.13 | 5,924,500 | |
12/05/2022 | 0.12 | 0.12 | 0.12 | 0.12 | 1,225,700 | |
12/02/2022 | 0.13 | 0.13 | 0.11 | 0.12 | 1,078,600 | |
12/01/2022 | 0.12 | 0.14 | 0.12 | 0.12 | 2,083,200 | |
11/30/2022 | 0.15 | 0.15 | 0.12 | 0.13 | 4,163,000 | |
11/29/2022 | 0.12 | 0.15 | 0.11 | 0.14 | 10,812,200 | |
11/28/2022 | 0.12 | 0.13 | 0.11 | 0.12 | 1,180,600 |
About Statera Biopharma Pink Sheet history
Statera Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Statera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Statera Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Statera Biopharma stock prices may prove useful in developing a viable investing in Statera Biopharma
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropeniaanemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the bodys immune system and restore homeostasis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people.
Statera Biopharma Pink Sheet Technical Analysis
Statera Biopharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
All Next | Launch Module |
Statera Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Statera Biopharma's price direction in advance. Along with the technical and fundamental analysis of Statera Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Statera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (1.60) | |||
Total Risk Alpha | (3.15) | |||
Treynor Ratio | 3.27 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Statera Pink Sheet
If you are still planning to invest in Statera Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Statera Biopharma's history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges |